Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

31 trials with published results (14%)

Research Maturity

152 completed trials (68% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.1%

7 terminated out of 223 trials

Success Rate

95.6%

+9.1% vs benchmark

Late-Stage Pipeline

7%

16 trials in Phase 3/4

Results Transparency

20%

31 of 152 completed with results

Key Signals

31 with results96% success

Data Visualizations

Phase Distribution

191Total
Not Applicable (122)
Early P 1 (4)
P 1 (27)
P 2 (22)
P 3 (8)
P 4 (8)

Trial Status

Completed152
Unknown25
Recruiting12
Active Not Recruiting10
Withdrawn8
Terminated7

Trial Success Rate

95.6%

Benchmark: 86.5%

Based on 152 completed trials

Clinical Trials (223)

Showing 20 of 20 trials
NCT05770570Phase 2Recruiting

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

NCT06440980Phase 1Completed

A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

NCT05841238Phase 1Completed

A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants

NCT05616013Phase 2Completed

Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

NCT07363148Not ApplicableNot Yet RecruitingPrimary

A Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults

NCT06200961Not ApplicableRecruiting

Trans-nasal Endoscopy for Bariatric Patients

NCT03528304Not ApplicableCompleted

Native Women's Wellness: Contingency Management for Tobacco Cessation and Weight Loss

NCT01399177CompletedPrimary

Influence of Changes in Food Group Variety on Food Cravings, Energy Intake, and Weight Loss After Bariatric Surgery

NCT07627919Not ApplicableRecruitingPrimary

Effect of Combined Resisted Training and Protein-based Diet on Frailty in Sarcopenic Elderly Women

NCT05316467Phase 2Terminated

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

NCT05313802Phase 1Completed

A Study of LY3502970 in Healthy Overweight and Obese Participants

NCT06186622Phase 1Completed

A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

NCT07559240Phase 1Not Yet Recruiting

A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy Participants

NCT07219589Phase 1Recruiting

A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

NCT07400588Phase 2Active Not RecruitingPrimary

Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

NCT07411560Phase 1Recruiting

A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese

NCT07205900Phase 2Active Not RecruitingPrimary

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

NCT06171152Early Phase 1Suspended

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

NCT07479862Phase 1Not Yet RecruitingPrimary

A Study of SA030 Injection in Overweight or Obese Participants

NCT04175678Not ApplicableActive Not Recruiting

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

Scroll to load more

Research Network

Activity Timeline